To determine the association between serum transferrin (Tf) concentration and overall survival in cancer patients specifically within the Chinese population.
Key Findings:
Serum transferrin levels were found to correlate with overall survival in cancer patients, suggesting its role as a prognostic marker.
Lower transferrin levels were associated with poorer nutritional status and increased cancer cachexia, indicating a potential area for intervention.
Transferrin serves as a potential prognostic marker for cancer survival, aligning with previous studies on nutritional biomarkers.
Interpretation:
The findings suggest that serum transferrin levels may be a valuable biomarker for predicting survival outcomes in cancer patients, highlighting the critical role of nutritional status in cancer prognosis.
Limitations:
The study is retrospective, which may introduce biases related to data collection and patient selection.
Data were collected from a specific population, limiting generalizability to other demographics.
Potential confounding factors related to treatment and disease progression were not fully controlled, which may affect the validity of the findings.
Conclusion:
Serum transferrin levels could serve as a significant prognostic indicator for overall survival in cancer patients, emphasizing the need for nutritional assessment in cancer care.
